Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/BF01834639.pdf
Reference45 articles.
1. Tubiana M, Pejovic MJ, Renaud A, Contesso G, Chavaudra N, Gioanni J, Malaise EP: Kinetic parameters and the course of the disease in breast cancer. Cancer 47: 937–943, 1981
2. Straus MJ, Moran RE: The cell cycle kinetics of human breast cancer. Cancer 46: 2634–2639, 1980
3. Silvestrini R, Daidone MG, Gasparini G: Cell kinetics as a prognostic marker in node-negative breast cancer. Cancer 56: 1982–1987, 1985
4. Gentili C, Sanfilippo O, Silvestrini R: Cell proliferation and its relationship to clinical features and relapse in breast cancers. Cancer 48: 974–979, 1981
5. Héry M, Gioanni J. Lalanne C-M, Namer M, Courdi A: The DNA labelling index: a prognostic factor in node-negative breast cancer. Breast Cancer Res Treat 9: 207–211, 1987
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A prospective, multicenter validation study of a prognostic index composed of S-phase fraction, progesterone receptor status, and tumour size predicts survival in node-negative breast cancer patients: NNBC, the node-negative breast cancer trial;Annals of Oncology;2013-09
2. Aneuploidy, but not Ki-67 or EGFR expression, is associated with recurrences in basal cell carcinoma;Journal of Cutaneous Pathology;2008-10
3. L'évaluation conjointe du contenu en ADN et de la fraction de cellules en phase S est un paramètre pronostique indépendant dans les cancers du sein de stades I et II;Cancer/Radiothérapie;2005-12
4. Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?;Annals of Oncology;2005-11
5. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer;Breast Cancer Research and Treatment;2005-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3